Skip to main content
Veterinary Medicines

SUVAXYN M HYO SUSPENSION FOR INJECTION FOR PIGS

Authorised
  • Mycoplasma hyopneumoniae, strain P-5722-3, Inactivated

Product identification

Medicine name:
SUVAXYN M HYO SUSPENSION FOR INJECTION FOR PIGS
SUVAXYN M. HYO SUSPENSION INJECTABLE POUR PORCINS
Active substance:
  • Mycoplasma hyopneumoniae, strain P-5722-3, Inactivated
Target species:
  • Pig (for fattening)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Mycoplasma hyopneumoniae, strain P-5722-3, Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (for fattening)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB13
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Box of 1 vial of 50 doses
  • Box of 10 vials of 50 doses
  • Box of 1 vial of 125 doses
  • Box of 10 vials of 125 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/4143631 4/2000
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0340/001
Concerned member states:
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 3/10/2024

Combined File of all Documents

English (PDF)
Published on: 10/09/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025